Literature DB >> 29756356

Neuroimaging abnormalities in individuals exhibiting Parkinson's disease risk markers.

Marcus Heldmann1, Janna Heeren1,2, Christine Klein2, Linus Rauch1,2, Johann Hagenah3, Thomas F Münte1, Meike Kasten2,4, Norbert Brüggemann1,2.   

Abstract

BACKGROUND: The concept of prodromal Parkinson's disease (PD) involves variable combinations of nonmotor features and subtle motor abnormalities as a result of ongoing neurodegeneration in the brain stem including substantia nigra (SN) and abnormal findings upon transcranial sonography and nuclear imaging. Except for nuclear imaging, the predictive value of risk markers for the conversion to overt PD is low.
OBJECTIVE: The objective of this study was to determine whether PD risk markers are associated with changes in brain structure and to what extent cognitive changes are risk markers for PD.
METHODS: Diffusion-weighted imaging, voxel-based morphometry, and cortical thickness analysis was performed in 29 individuals with hyposmia and/or an increased SN hyperechogenicity (SN+) upon transcranial sonography and 28 controls without these 2 risk markers. Classical parkinsonian signs were an exclusion criterion. All of the participants underwent a neuropsychological test battery addressing executive functions, learning ability, and verbal fluency.
RESULTS: In the PD risk group, diffusion-weighted imaging mean diffusivity was increased in 4 left hemisphere clusters (posterior thalamus, inferior longitudinal fasciculus, fornix, corticospinal tract). A negative relationship of mean diffusivity and smell function was present for the posterior thalamus and the corticospinal tract. There was a significant correlation of mean diffusivity values and SN+ in all clusters. Neither voxel-based morphometry nor cortical thickness analysis revealed any group differences. No relevant group differences were observed for cognitive tests included.
CONCLUSION: PD-free individuals with PD risk markers show microstructural changes of the white matter, including areas relevant for motor and limbic processes. In addition, our study provides for the first time a neuroanatomical correlate for SN hyperechogenicity.
© 2018 International Parkinson and Movement Disorder Society. © 2018 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease risk markers; diffusion-tensor imaging; hyposmia; substantia nigra; transcranial sonography

Mesh:

Year:  2018        PMID: 29756356     DOI: 10.1002/mds.27313

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  Distinct Relationship Between Cognitive Flexibility and White Matter Integrity in Individuals at Risk of Parkinson's Disease.

Authors:  Haidar Alzaid; Thomas Ethofer; Markus A Hobert; Bernd Kardatzki; Michael Erb; Walter Maetzler; Daniela Berg
Journal:  Front Aging Neurosci       Date:  2020-08-13       Impact factor: 5.750

2.  Feature Fusion and Detection in Alzheimer's Disease Using a Novel Genetic Multi-Kernel SVM Based on MRI Imaging and Gene Data.

Authors:  Xianglian Meng; Qingpeng Wei; Li Meng; Junlong Liu; Yue Wu; Wenjie Liu
Journal:  Genes (Basel)       Date:  2022-05-07       Impact factor: 4.141

3.  Discordance in monozygotic Parkinson's disease twins - continuum or dichotomy?

Authors:  Alexander Balck; Max Borsche; Meike Kasten; Katja Lohmann; Philip Seibler; Norbert Brüggemann; Christine Klein
Journal:  Ann Clin Transl Neurol       Date:  2019-05-02       Impact factor: 4.511

Review 4.  Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.

Authors:  Bruce A Chase; Katerina Markopoulou
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

5.  Repeated anodal high-definition transcranial direct current stimulation over the left dorsolateral prefrontal cortex in mild cognitive impairment patients increased regional homogeneity in multiple brain regions.

Authors:  Fangmei He; Youjun Li; Chenxi Li; Liming Fan; Tian Liu; Jue Wang
Journal:  PLoS One       Date:  2021-08-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.